Advertisement
Canada markets closed

  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • Bitcoin CAD

    83,273.12
    -2,802.02 (-3.26%)
     

  • CMC Crypto 200

    1,265.58
    -92.42 (-6.81%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     

  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     
MARKETS LIVE BLOG:

STOCKS CLIMB AS DOW POSTS 8TH STRAIGHT WIN

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

THE MEDICINES COMPANY SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

ACCESSWIRE

WILMINGTON, DE / ACCESSWIRE / November 25, 2019 / Rigrodsky & Long, P.A.:

  • Do you own shares of The Medicines Company (NASDAQ GS:MDCO)?

  • Did you purchase any of your shares prior to November 24, 2019?

  • Do you think the proposed buyout is fair?

  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors The Medicines Company (the "Company") (NASDAQ GS:MDCO) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Novartis AG ("Novartis") in a transaction valued at approximately $9.7 billion. Under the terms of the agreement, shareholders of The Medicines Company will receive $85.00 in cash for each share of The Medicines Company they own.

If you own common stock of The Medicines Company and purchased any shares before November 24, 2019, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra toll-free at (888) 969-4242, by e-mail at info@rl-legal.com, or at https://www.rigrodskylong.com/offices-contact.

ADVERTISEMENT

Rigrodsky & Long, P.A., with offices in Delaware, New York, and California, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in numerous cases nationwide, including federal securities fraud actions, shareholder class actions, and shareholder derivative actions.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com

SOURCE: Rigrodsky & Long, P.A.



View source version on accesswire.com:
https://www.accesswire.com/567982/THE-MEDICINES-COMPANY-SHAREHOLDER-ALERT-Rigrodsky-Long-PA-Announces-Investigation-Of-Buyout